Hans Christian Andersen Children's Hospital
Odense, Odense C, 5000, Denmark
Location status: Recruiting
NCT Number: NCT04331522
A prospective study of all allergen provocations performed in children at the Hans Christian Andersen Children's Hospital.
Interested in participating?
Request Info0 year–18 year
All sexes
Observational
Odense, Odense C, 5000, Denmark
Location status: Recruiting
The purpose of the study is to investigate the impact of co-morbidities, history, and allergen tests on the outcome of allergen provocation tests.
Subjects are children aged 0-18 years old investigated for allergy to foods or antibiotics. Data entered in the database are demographics, co-morbidities, symptoms, SPT, specific IgE and details of the allergen provocations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
clinical suspicion of allergy to foods or antibiotics informed concent -
Exclusion criteria
-
Titrated provocation with allergen
Time frame: 5 years
The value of specific IgE and SPT to predict the outcome of a allergen provocation
Contact information is provided by the study sponsor or research team.
Josefine Gradman, phd
CONTACT
Susanne Halken, DMSc
CONTACT
Josefine Gradman
Other
Allergen Provocations at Hans Christian Andersen Children's Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07341776
Allergy in Children, Anaphylactic Reaction
Basel, Switzerland
View Trial DetailsNCT06421415
Allergy in Children
Odense, Odense C, Denmark
View Trial Details